Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
EBT-101 is novel gene-editing therapy that uses “molecular scissors” to cut HIV out of cells.
Experimental vaccine aims to train B cells to produce broadly neutralizing antibodies that target HIV.
A new case may provide clues to help researchers develop strategies for a functional cure.
The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
Early treatment is linked to a smaller viral reservoir, but blocking IL-10 and PD-1 might control the virus in those with chronic infection.
The woman has had an undetectable viral load and a normal CD4 count for more than 12 years after stopping antiretroviral therapy.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
Loreen Willenberg is part of a group of elite controllers whose HIV appears to be locked away where it can’t produce new virus.
An experimental approach to protect HIV-fighting T cells has been cleared for its first human trial.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
A small HIV vaccine study yields interesting findings.
The U.S. Food and Drug Administration (FDA) has given the green light to an early human trial of an HIV gene therapy that may lead to a...
One researcher likened the treatment to creating a new ’mini-organ’ in the body.
Another reason to know your status: Among those who start antiretroviral medications right after getting HIV, more report cures and remissions...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.